- Title
- What is next in ALS clinical trials?
- Creators
- Noam Y. HarelWalter G Bradley - UMMG Department of Neurology
- Publication Details
- Neurology, Vol.70(16), pp.1365-1365
- Publisher
- Lippincott Williams & Wilkins
- Number of pages
- 1
- Grant note
- K08NS056212 / NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS) K08 NS056212 / NINDS NIH HHS; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)
- Academic Unit
- Miller School of Medicine; UMMG Department of Neurology; UMMG Dept of Neurology - Neuromuscular Disorders Div
- Language
- English
- Resource Type
- Journal article
- PMID
- 18413594
- Record Identifier
- 991031713512902976
Journal article
What is next in ALS clinical trials?
Neurology, Vol.70(16), pp.1365-1365
2008-04-15
PMID: 18413594
Metrics
7 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Citation topics
- 1 Clinical & Life Sciences
- 1.52 Neurodegenerative Diseases
- 1.52.765 Amyotrophic Lateral Sclerosis
- Web Of Science research areas
- Clinical Neurology
- ESI research areas
- Neuroscience & Behavior
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites